Invention Grant
- Patent Title: Opioid formulations
-
Application No.: US17142673Application Date: 2021-01-06
-
Publication No.: US11110084B2Publication Date: 2021-09-07
- Inventor: Fredrik Tiberg , Ian Harwigsson , Markus Johnsson
- Applicant: Camurus AB
- Applicant Address: SE Lund
- Assignee: Camurus AB
- Current Assignee: Camurus AB
- Current Assignee Address: SE Lund
- Agency: Choate, Hall & Stewart LLP
- Agent Charles E. Lyon; Michael A. Shinall
- Main IPC: A61K31/4748
- IPC: A61K31/4748 ; A61K31/485 ; A61K47/10 ; A61K47/24 ; A61K47/34 ; A61K9/00 ; A61K47/14
Abstract:
A depot precursor formulation comprising:
a) a controlled-release matrix;
b) at least oxygen containing organic solvent;
c) at least 12% by weigh of at least one active agent selected from buprenorphine and salts thereof, calculated as buprenorphine free base.
Corresponding depot compositions and methods of treatment in pain management, by opioid maintenance and related methods are provided.
a) a controlled-release matrix;
b) at least oxygen containing organic solvent;
c) at least 12% by weigh of at least one active agent selected from buprenorphine and salts thereof, calculated as buprenorphine free base.
Corresponding depot compositions and methods of treatment in pain management, by opioid maintenance and related methods are provided.
Public/Granted literature
- US20210137916A1 OPIOID FORMULATIONS Public/Granted day:2021-05-13
Information query
IPC分类:
